Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07177638 · ClinicalTrials.gov registry record · NA
A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.
A NA study of Skin Cancer, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT07177638: Active NA study of Skin Cancer, sponsored by NYU Langone Health.
NCT07177638 is a NA study of Skin Cancer that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 45 participants, below the 463-participant average among 40 other Skin Cancer trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07177638, a NA study of Skin Cancer, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study of a community- based melanoma educational intervention in Bensonhurst, Brooklyn conducted in-person by a community-health worker employed by the Perlmutter Cancer Center. Sample size will be around 35 participants. The participants will complete a pre-study survey and then take part in the educational session. There will be follow up study visits to assess the impact of the intervention on participant knowledge and skin self-examination behaviors at 3 weeks, 3 months, 6 months, and 12 months. At the 12-month mark, the participants will also complete a post-study survey.
Primary Outcome
Melanoma knowledge/awareness will be assessed using a study questionnaire. Each item is multiple choice with 1 correct answer: the total score is the percentage of correct responses and ranges from 0-100%.
Conditions Studied
Interventions
- BEHAVIORAL Education Sessions to Improve Melanoma Knowledge and Awareness
Study Locations (1)
New York
- Jewish Community House of Bensonhurst - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2026-08-27 |
| Phase | NA |
What the registry record for NCT07177638 still lists
NCT07177638 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 463-participant average among 40 other Skin Cancer trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Skin Cancer appearing as the primary indexed condition, and to 1 intervention - of which Education Sessions to Improve Melanoma Knowledge and Awareness is the first listed.
NCT07177638 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07177638 about?
NCT07177638 is a clinical study titled "A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.". This is a pilot study of a community- based melanoma educational intervention in Bensonhurst, Brooklyn conducted in-person by a community-health worker employed by the Perlmutter Cancer Center. Sample size will be around 35 participants. The participants will complete a pre-study survey and then tak...
What is the current status of trial NCT07177638?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2025-08-01. Estimated completion is 2026-08-27.
What conditions does trial NCT07177638 study?
This clinical trial studies the following conditions: Skin Cancer.
What interventions are being tested in trial NCT07177638?
The interventions under investigation include: Education Sessions to Improve Melanoma Knowledge and Awareness (BEHAVIORAL).
Who is sponsoring clinical trial NCT07177638?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07177638 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07177638's enrollment target sits among peer trials
45 25th of 40 higher than 16 of 40 other Skin Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rural Adult and Youth Sun Protection Study
RECRUITING · NA
-
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
RECRUITING · NA
-
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
RECRUITING · NA
-
DNA Repair Activity in the Skin of Day and Night Shift Workers
RECRUITING · NA
-
Adaptive Symptom Self-Management Immunotherapy Study
RECRUITING · NA
-
Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI